A shared care model can help community oncology practices stay connected with patients when care extends beyond the local practice. Instead of treating a referral to a specialist, academic center, or clinical trial site as a complete transfer, shared care creates a way for physicians to collaborate while the community oncologist remains involved. This can support continuity, communication, and the established oncologist-patient relationship.
In this setting, a shared care model for patient retention is less about preventing patients from seeking care elsewhere and more about making sure additional expertise can be accessed without unnecessary disruption to the relationship they already have with their physician.
What Does Patient Retention Mean in Oncology?
Patient retention in oncology should be considered alongside continuity of care. A patient may need a second opinion, a subspecialist, or access to a clinical trial without ending the relationship with the community oncologist.
Cancer treatment can involve several providers and institutions. When those teams communicate effectively, patients may be able to receive specialized services while continuing appropriate care closer to home.
The goal is not to discourage referrals. Patients should have access to care that meets their individual needs. Instead, the goal is to create a coordinated pathway in which the community oncologist remains informed and involved when appropriate.
This distinction is important for community oncology patient retention because a referral does not have to become a complete handoff.
Why Can Practices Lose Patients After a Referral?
A referral can change the patient relationship when communication between providers becomes difficult. A patient may visit another institution, receive new recommendations, and then be uncertain about what happens next.
Several issues can contribute to this:
- Information may not move efficiently between institutions.
- Patients may be unsure which physician is responsible for a particular part of care.
- Follow-up with the referring oncologist may become less consistent.
- The receiving institution may become the patient’s primary point of contact.
These challenges do not necessarily reflect a lack of commitment from physicians. Oncology care often crosses organizational boundaries, while communication systems may not be designed around that reality.
A shared care model can address the connection between providers so that patients do not have to manage every transition themselves.
How Does a Shared Care Model Support Patient Retention?
A shared care model patient retention approach changes the way a referral is viewed. Rather than being a one-way transfer, the referral becomes part of an ongoing collaboration.
A community oncologist may identify a patient who could benefit from a specialist consultation or clinical trial evaluation. Another physician can provide additional expertise while the community oncologist remains aware of the patient’s progress and continues the aspects of care that fall within their role.
The exact arrangement will depend on the patient, treatment plan, participating providers, and clinical trial requirements. The underlying principle remains the same: care can involve multiple institutions without communication stopping between them.
1104Health describes its Shared Care Network as a physician-first model designed to help oncologists collaborate, coordinate patient care, share expertise, and remain connected throughout the patient’s journey. The platform also positions clinical trials as part of coordinated cancer care rather than as a separate pathway.
Keeping the Community Oncologist Involved
A community oncologist may already understand a patient’s treatment history, preferences, and concerns. That established relationship can remain valuable when another provider becomes involved.
Shared care does not require one physician to manage every aspect of treatment. Instead, the participating teams can clarify who is responsible for specific decisions, appointments, treatments, and follow-up.
This clarity can also make the experience easier for patients. When patients understand which physician is handling a particular concern, they have a clearer point of contact and may spend less time trying to determine where a question belongs.
1104Health’s approach includes communication between physicians and ongoing updates during clinical trial care. Its materials also describe a process in which patients can return to their community oncologist after completing a trial, with relevant information shared for the transition.
The Role of Cross-Institution Patient Sharing
Cross-institution patient sharing becomes important when a patient needs expertise or services outside the community practice. However, sharing a patient responsibly requires more than making an introduction.
Participating providers need a practical way to communicate. Relevant information should reach the appropriate care team, responsibilities should be understood, and updates should be available to physicians who remain involved.
1104Health’s Shared Care Network is built around this type of collaboration. The company describes tools for physician-to-physician communication, shared care planning, clinical trial awareness, and coordination between community oncologists and specialists.
For patients, the value is not simply having more physicians involved. It is having those physicians work from a connected understanding of the care journey.
How Patient Trust Shapes the Oncologist-Patient Relationship
Patient trust in oncology can develop through communication, consistency, respect, and transparency. A referral may create questions for patients, particularly when they are already managing a complex diagnosis or treatment plan.
They may wonder whether their local oncologist will remain involved, whether they need to repeat their medical history, or whether the referral represents a permanent change in care.
A clear conversation can help. The community oncologist can explain why another provider is being involved and what the consultation or trial evaluation is intended to address. Continued communication between physicians can reinforce the understanding that the patient remains part of a coordinated care process.
Trust should not be used to limit patient choice. Patients should have appropriate information and the opportunity to discuss their care options with their healthcare professionals.
Can Patients Stay With Their Community Oncologist During a Clinical Trial?
In some circumstances, patients may remain connected with their community oncologist while receiving clinical trial-related care through another institution. However, this depends on the individual trial, its protocol, the participating sites, and the responsibilities assigned to each care team.
Clinical trials may have specific requirements involving visits, testing, treatment administration, documentation, and follow-up. These requirements determine what can be managed locally.
For this reason, communication should begin before the patient enters the trial pathway. The community oncologist and trial team can clarify their roles and establish how relevant updates will be shared.
1104Health specifically describes its Shared Care approach as a way to keep local physicians informed during trial participation and support the patient’s transition back to community care when appropriate.
Explore the 1104Health Shared Care Network
The arrangement should always follow the clinical trial protocol and the responsibilities established by the participating providers.
How Do Physician Incentives Affect Patient Retention?
Physician incentives in oncology discussions require a balanced approach. Patient retention should not be reduced to revenue, nor should financial considerations influence whether a patient receives an appropriate referral.
Community practices invest time in patient care, case review, referral coordination, and communication with outside specialists. A model that recognizes the time and effort required for these activities can make collaboration more sustainable.
1104Health includes compensation within its Shared Care Network for physician time. The company presents this as part of a model designed to align incentives around collaboration and patient access.
The important distinction is transparency. Physician incentives should support appropriate collaboration rather than discourage patients from accessing specialists, trials, or other clinically relevant services.
Care Coordination Benefits for Community Oncology
The care coordination benefits of shared care extend beyond patient retention. When several providers participate in treatment, organized communication can help reduce some of the administrative challenges associated with moving between institutions.
A coordinated process can help teams:
- Keep appropriate physicians informed about the patient’s progress.
- Clarify responsibilities during referrals and trial participation.
- Connect community oncologists with specialists and investigators.
- Give patients clearer information about the next stage of care.
- Support transitions between institutions with relevant updates.
These are coordination benefits, not promises of a particular clinical result. Each patient’s circumstances are different, and treatment decisions remain with the appropriate healthcare professionals.
For community practices, the broader value is the ability to collaborate with outside providers while maintaining the local physician relationship when appropriate.
How 1104Health Supports the Shared Care Model
1104Health was built around the challenge of fragmented cancer care. Its stated mission is to replace fragmented care with a shared care model that keeps physicians connected and involved throughout the patient journey.
Its Shared Care Network brings together oncologists, clinical investigators, navigators, and other care team members. The platform supports clinical trial matching, collaborative care planning, physician communication, education, and patient navigation.
For a community oncologist, this model is intended to provide a structured way to collaborate when a patient needs specialized input or may be appropriate for a clinical trial. The focus remains on supporting the treating physician rather than replacing that physician’s role.
That distinction is central to the model. Shared care is not simply about moving patients between practices. It is about creating a connected pathway between physicians.
Building a More Connected Patient Journey
A shared care process begins with communication. Patients should understand why another provider is being involved, while participating physicians should understand their respective responsibilities.
Several practices can support this process:
- Explain the reason for the referral in clear, patient-friendly language.
- Establish which provider will manage specific aspects of care.
- Keep the community oncologist informed when clinically appropriate.
- Give patients clear points of contact during transitions.
- Plan for continued local care when the clinical arrangement permits it.
These steps cannot guarantee patient retention. They can, however, create a structure in which patients can access additional expertise while maintaining continuity where appropriate.
For community oncology patient retention, that distinction matters. A patient should not have to choose between specialized services and an established local relationship when the participating teams can coordinate effectively.
Conclusion
Community oncology patient retention is closely connected to continuity. Patients may need specialists, academic centers, or clinical trial teams during their treatment, but those referrals do not necessarily have to end the relationship with the community oncologist.
A shared care model for patient retention provides another path. Physicians can share expertise, communicate across institutions, and coordinate care while keeping the patient’s existing relationship in view.
1104Health’s Shared Care Network is designed around this principle, connecting community oncologists with specialists, investigators, and care teams while supporting physician involvement throughout the patient’s journey.
The broader goal is straightforward: patients should be able to consider appropriate care options without unnecessary fragmentation, while physicians have a practical way to remain connected when care crosses institutional boundaries.
Frequently Asked Questions
1. What does patient retention mean in oncology?
Patient retention in oncology can refer to maintaining an ongoing relationship between a patient and their community oncology practice while the patient receives additional services when needed. It does not mean preventing referrals or limiting patient choice.
2. Does shared care help keep patients with their local oncologist?
A shared care arrangement can support continued involvement from the community oncologist when the patient’s clinical needs and participating institutions allow it. It does not guarantee that a patient will remain with one practice.
3. What role does trust play in physician referrals?
Trust can help patients understand why another provider is being involved. When the community oncologist communicates openly and remains appropriately connected to the patient’s care, the referral may feel more like collaboration than a complete transfer.
4. What causes practices to lose patients after a referral?
Communication gaps, unclear responsibilities, limited follow-up, and changes in where the patient receives treatment can affect continuity. A structured shared care process can help participating providers maintain communication as care moves between settings.
